Your Comments On...

MERGERS & ACQUISITIONS

Swiss pharmaceutical maker Roche offered $43.7 billion for the remaining shares of its U.S. biotech partner Genentech, seizing an opportunity to increase earnings from Genentech drugs.
 
Comments
© 2008 The Washington Post Company